Segre G, Cerretani D, Bruni G, Urso R, Giorgi G
Istituto di Farmacologia, University of Siena, Italy.
Eur J Drug Metab Pharmacokinet. 1998 Apr-Jun;23(2):218-22. doi: 10.1007/BF03189343.
The kinetics of amiloride was investigated in plasma, urine, faeces and tissues of rats after oral (10 mg/kg) and i.v. (10 mg/kg bolus and 35 microg/h for 4-days infusion) administration. Initially the experimental data were analyzed by a multiexponential model, then a compartmental model was developed to describe the drug kinetics in plasma, urine, faeces and tissues after the i.v. bolus and the oral administration simultaneously. Aim of the model was also to predict the drug kinetics in plasma and tissues of rats after continuous i.v. infusion. The results of the prediction and the discrepancies between prediction and observed data allowed a deeper insight into the pharmacokinetics of amiloride.
在大鼠口服(10毫克/千克)和静脉注射(静脉推注10毫克/千克以及持续4天以35微克/小时的速率输注)给药后,研究了氨氯吡咪在大鼠血浆、尿液、粪便和组织中的动力学。最初,实验数据通过多指数模型进行分析,然后建立了一个房室模型,以同时描述静脉推注和口服给药后血浆、尿液、粪便和组织中的药物动力学。该模型的目的还在于预测大鼠持续静脉输注后血浆和组织中的药物动力学。预测结果以及预测数据与观测数据之间的差异,使我们能够更深入地了解氨氯吡咪的药代动力学。